# Chapter 7
| # |                                                                              Citation                                                                               |                               DOI                                |
|--:|---------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------|
| 13|McKeigue, P. M., Lamm, S. H., Linn, S., & Kutcher, J. S. (1994). Bendectin and birth defects: I. A meta-analysis of the epidemiologic studies. Teratology, 50, 27–37.|[10.1002/tera.1420500105](https://doi.org/10.1002/tera.1420500105)|

# Chapter 8
| # |                                                                                                               Citation                                                                                                                |                                         DOI                                          |
|--:|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------|
|  3|Wong, F. C. K., & Lo, Y. M. D. (2016). Prenatal Diagnosis Innovation: Genome Sequencing of Maternal Plasma. Annual Review of Medicine, 67, 419–432.                                                                                    |[10.1146/annurev-med-091014-115715](https://doi.org/10.1146/annurev-med-091014-115715)|
| 10|Sundberg, K., Bang, J., Smidt-Jensen, S., Brocks, V., Lundsteen, C., Parner, J., … Philip, J. (1997). Randomised study of risk of fetal loss related to early amniocentesis versus chorionic villus sampling. The Lancet, 350, 697–703.|[10.1016/S0140-6736(97)02449-5](https://doi.org/10.1016/S0140-6736(97)02449-5)        |

# Chapter 13
| # |                                                                   Citation                                                                   |                                      DOI                                       |
|--:|----------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------|
|  1|GEDEON, C., & KOREN, G. (2006). Designing Pregnancy Centered Medications: Drugs Which Do Not Cross the Human Placenta☆. Placenta, 27, 861–868.|[10.1016/j.placenta.2005.09.001](https://doi.org/10.1016/j.placenta.2005.09.001)|

